Cancer Treatment May Result In Bone Loss

Main Category: Breast Cancer
Also Included In: Prostate / Prostate Cancer;  Bones / Orthopedics
Article Date: 16 Nov 2008 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (3 votes)

Healthcare Prof:5 stars

5 (1 votes)


New cross-Canada study in Journal of Clinical Oncology outlines risks

A new cross-Canada study has found that breast and prostate cancer treatment can foster bone loss. In the online edition of the Journal of Clinical Oncology, the scientists explain how loss of bone mass might affect 46,000 people diagnosed with breast and prostate cancer each year* and place them at increased risk for osteoporosis and fractures.

"Our study also looked at possible medications that can reverse or halt bone loss," says Dr. Fred Saad, lead author and director of urologic oncology at the Université de Montréal's Faculty of Medicine and the Centre Hospitalier de l'Université de Montréal (CHUM), who completed the exhaustive study with colleagues from McMaster University, the Université Laval, the University of Toronto and the University of British Columbia.

"Bone is a dynamic tissue which undergoes a cyclic process of breaking down and rebuilding," adds Dr. Saad. "Medications called bisphosphonates help with the rebuilding process and have been successfully used to combat osteoporosis, which is good news for cancer patients."

Evaluating the studies

Dr. Saad and colleagues evaluated data from more than 3,500 breast and prostate cancer studies. They concluded that breast cancer patients treated with aromatase inhibitors were more likely to have bone loss and fractures compared to patients who didn't receive the therapy. Similarly, men who received androgen deprivation therapy to treat their prostate cancer had an increased risk of bone disorders. Although the numbers vary from one study to the next (from five to 45 percent), an elevated risk is consistently observed.

"Awareness of the incidence of cancer-associated bone loss raises issues for clinicians who should identify those patients who are most at risk for fractures and prescribe treatment strategies," says Dr. Saad. "This information is not only a concern for the specialists, but also for the general practitioners who frequently encounter these patients."

Bisphosphonate treatment reduces bone loss

Dr. Saad's group also evaluated data that included bisphosphonate treatment for cancer patients receiving chemotherapy. Prostate cancer patients who received bisphosphonate treatment and androgen deprivation therapy did show an increase in bone loss. In the same vane, there was a protective effect on bone loss for breast cancer patients who were treated with bisphosphonates.

"It is clear that the use of bisphosphonates attenuates bone loss," concludes Dr. Saad. "However, the optimal dosing and long-term impact is unclear and needs to be determined. Other measures to combat the bone loss, such as exercise, vitamin D intake, avoidance of cigarettes, may also be beneficial

###

*(Re: Canadian Cancer Society)

This press release is available in French.

About the study:

The article "Cancer Treatment-Induced Bone Loss in Breast and Prostate Cancer" (http://www.jco.ascopubs.org/cgi/reprint/JCO.2008.18.4184v1), published in the Journal of Clinical Oncology, was authored by Fred Saad from the Université de Montréal and the Centre hospitalier de l'Université de Montréal; Jonathan D. Adachi of McMaster University; Jacques P. Brown of the Université Laval; Leah A. Canning and Karen A. Gelmon of the University of British Columbia; Robert G. Josse and Kathleen I. Pritchard of the University of Toronto.

Partners in research:

This study was funded through grants from Sanofi-Aventis.

On the Web:

About the Journal of Clinical Oncology: http://www.jco.ascopubs.org
About the Université de Montréal: http://www.umontreal.ca/english/index.htm
About the Centre Hospitalier de l'Université de Montréal http://www.chumtl.qc.ca/accueil.fr.html
About McMaster University: http://www.mcmaster.ca
About the Université Laval: www.ulavhttp://www.ulaval.caal.ca
About the University of Toronto: http://www.utoronto.com
About the University of British Columbia: http://www.ubc.ca

Source: Sylvain-Jacques Desjardins
University of Montreal

Article adapted by Medical News Today from original press release.
Visit our breast cancer section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Sylvain-Jacques Desjardins. "Cancer Treatment May Result In Bone Loss." Medical News Today. MediLexicon, Intl., 16 Nov. 2008. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/129429.php>

APA
Sylvain-Jacques Desjardins. (2008, November 16). "Cancer Treatment May Result In Bone Loss." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/129429.php.

Please note: If no author information is provided, the source is cited instead.


Breast Cancer

What Is Breast Cancer?

Breast cancer is a tumor that has become malignant - it has developed from the breast cells. A 'malignant' tumor can spread to other parts of the body - it may also invade surrounding tissue. When it spreads around the body, we call it 'metastasis'. Read more...

Most Popular Articles



Follow Our Breast Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Breast Cancer Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »